Evaluation of the role of Lymphadenectomy In high-risk Prostate cancer SurgEry
When treating high-risk prostate cancer that has not spread elsewhere, surgeons remove the prostate gland. Sometimes, they also remove nearby pelvic lymph nodes—small glands that cancer cells can spread to first. Removing these glands might clear more cancer, but it takes longer and can cause extra surgical complications, such as swelling or fluid build-up. Currently, UK surgeons disagree on whether removing these lymph nodes is truly helpful, and standard practice varies between hospitals. The ELIPSE study aims to settle this question. Around 1,080 men across 25 UK hospitals will take part. Participants will be randomly assigned to have their prostate removed either with or without the nearby lymph nodes. Both techniques are already standard NHS care. Researchers will follow participants for three years using simple questionnaires to compare cancer recovery, side effects, and overall quality of life.
At a glance
What is this study about?
Prostate cancer is the most common cancer in men in the UK. When it is described as 'high-risk localised', it means tests show the cancer is still contained within or just around the prostate, but it has features that make it likely to grow or spread if left untreated. A common treatment aimed at curing this cancer is an operation called a radical prostatectomy, where surgeons remove the entire prostate gland.
During this operation, surgeons must decide whether to also remove nearby pelvic lymph nodes. Lymph nodes are tiny immune glands that act as filters throughout the body, and they are usually the first place prostate cancer cells travel to. Removing them may help clear away hidden cancer cells and stop the disease from returning. However, taking them out makes the operation longer and carries a risk of complications, such as fluid pooling in the pelvis or lasting leg swelling, which can harm daily quality of life.
Right now, medical evidence cannot prove whether removing these glands actually helps men live longer and healthier lives. Because of this uncertainty, practice varies widely across the NHS: some surgeons routinely remove lymph nodes, while others do not. UK doctors urgently need clear evidence so they can offer all patients the best possible advice.
The ELIPSE trial is designed to answer this question. By directly comparing both standard surgical options across 1,080 men in 25 NHS hospitals, the study will show which method provides the best balance between clearing the cancer and keeping recovery safe and comfortable.
Key takeaways
- The ELIPSE study compares prostate cancer surgery with and without the removal of nearby lymph nodes.
- Both surgical options are standard, widely used procedures across the NHS.
- Participants are randomly assigned to one of the two surgical methods.
- Recovery and quality of life are monitored over three years using home questionnaires.
- The findings will help establish clear UK guidelines on the best surgical care for high-risk prostate cancer.
Who may be eligible?
This study is open to men aged 18 and older who have been diagnosed with high-risk prostate cancer that has not spread to other parts of the body. Your hospital specialist cancer team must have confirmed your diagnosis through a tissue biopsy and scans, and agreed that an operation to remove your prostate is an appropriate treatment for you.
You cannot take part if you have received hormone therapy for prostate cancer in the three months before joining, or if you have previously had major treatments for prostate cancer, such as radiotherapy, prior prostate surgery, or focal therapies (like freezing cancer cells). Men who are unable to safely undergo surgery or who cannot give informed consent are also not eligible.
Could this study suit you?
Answer these quick questions to see if you may be eligible. This is a guide only — the research team makes the final call.
- I am a man aged 18 or older.
- I have biopsy-confirmed high-risk prostate cancer that has not spread elsewhere.
- My medical team has agreed that surgery to remove my prostate is suitable for me.
- I have not had hormone treatment for prostate cancer in the last 3 months.
- I have not had prior radical prostate cancer treatments, such as surgery or radiotherapy.
What does participation involve?
If you decide to take part, a computer will randomly allocate you to have your prostate removed either with or without the nearby lymph nodes. You have an equal 50/50 chance of receiving either operation. Both options are routine, standard NHS treatments already performed regularly across the UK.
Your operation will go ahead at your local hospital as planned. You will not need extra hospital trips just for the study. Instead, the research team will monitor your progress for three years (36 months) through short questionnaires sent to your home at set times. These forms will ask about your physical recovery, quality of life, any side effects, and when you were able to return to your normal routine. The researchers will also collect routine health updates directly from your standard NHS hospital records.
Potential risks and benefits
Locations (33)
- Cardiff & Vale University LhbCity onlyCardiff, Wales
- Royal Liverpool University HospitalApproximateLiverpool, England
- Gartnavel Royal HospitalApproximateGlasgow, Scotland
- St James University Hospital NHS TrustCity onlyLeeds, England
- Aberdeen Royal InfirmaryApproximateAberdeen, Scotland
- University Hospital (coventry)UnverifiedCoventry, England
- Guy's and St Thomas' NHS Foundation TrustUnverifiedLondon, England
- Charing Cross HospitalUnverifiedLondon, England
- Darent Valley HospitalUnverifiedDartford, England
- Lincoln County Hospital LaboratoryUnverifiedLincoln, England
- Royal Hallamshire HospitalUnverifiedSheffield, England
- Nottingham University Hospitals NHS Trust - City CampusUnverifiedNottingham, England
Common questions
What are pelvic lymph nodes?
Lymph nodes are small, bean-shaped glands that form part of your immune system. In prostate cancer, the nodes in the pelvis are usually the first place cancer cells travel if they spread beyond the prostate gland.
Can I choose which type of surgery I receive?
No. To ensure the comparison is completely fair and unbiased, a computer will randomly assign you to have the lymph nodes removed or left in place.
Is one surgical option considered safer than the other?
Both approaches are standard, approved NHS treatments. While leaving the nodes in place is a slightly shorter operation with fewer potential swelling risks, removing them may potentially catch hidden cancer cells. The study is being run to find out which approach provides the best overall outcome.
Will taking part mean extra hospital appointments?
No. Your surgery and follow-up check-ups will follow your hospital's normal routine. The trial follow-up is completed through questionnaires sent to your home and information from your existing medical records.
What happens if I change my mind later on?
You are free to leave the trial at any point without giving an explanation. Your clinical team will continue to provide you with the best possible NHS care.
How to find out more
Maria Ntessalen
Always speak to your GP or specialist before deciding to take part in a study.
Discussion
Community discussion
Powered by our forum at community.patient.info. Please be respectful — this is not medical advice.